Daniel Lee
Urology · Lebanon, PANPI 1871818880
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,000 of the $10,762 with a category attached, or 65.0%. Intuitive Surgical accounts for 73.8% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $5,408 and has fallen 93.0% since, to $380 in 2025.
Across 35 payments — averaging $307.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- AbbVie$1K
- Photocure Inc$408
- Johnson & Johnson$405
- Urogen Pharma, Inc.$307
- Acclarent, Inc$247
- plus $346 from 6 others
Across 2 payments — averaging $11,999 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Urogen Pharma, Inc.$24K
What the payments were for
- Consulting fees$1,0009%
- Travel & lodging$6316%
- Food & beverage$2,13120%
- Education$7,00065%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $7,942 |
| AbbVie | 2 | $1,106 |
| Photocure Inc | 3 | $408 |
| Johnson & Johnson | 5 | $405 |
| Urogen Pharma, Inc. | 2 | $307 |
| Acclarent, Inc | 2 | $247 |
| KARL Storz Endoscopy-america | 1 | $133 |
| Baxter Healthcare | 2 | $59 |
| Ferring Pharmaceuticals Inc. | 2 | $49 |
| Boston Scientific | 2 | $47 |
| Janssen Scientific Affairs, LLC | 1 | $34 |
| Coloplast | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$7,801
- Cysview$340
- JELMYTO$307
- TruDi Nav Cable$247
- Erleada$241
- AKEEGA$241
- FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM$133
How this compares
$10,762 in reported general payments places this provider in the 85th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 103 | $911 |
| Finasteride | 89 | $855 |
| Oxybutynin Chloride ErOxybutynin Chloride | 19 | $510 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 16 | $330 |
| Dutasteride | 11 | $236 |
| Doxazosin Mesylate | 11 | $102 |
| Oxybutynin Chloride | 12 | $102 |
Paid to pharmacies, not to this prescriber.
Other urology in Lebanon
- John AndersonBethlehem$2.1M
- Demetrius BagleyPhiladelphia$739K
- Paul SieberLancaster$631K
- Daniel EunPhiladelphia$226K
- Leonard GomellaPhiladelphia$190K
- Anthony DimatteoButler$189K
- Angelo BaccalaAllentown$166K
- Phillip GinsbergPhiladelphia$145K
- Edouard TrabulsiPhiladelphia$137K
- Siobhan HartiganPhiladelphia$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.